» Articles » PMID: 18372923

Alpha-tocopheryl Succinate Induces Apoptosis by Targeting Ubiquinone-binding Sites in Mitochondrial Respiratory Complex II

Overview
Journal Oncogene
Date 2008 Apr 1
PMID 18372923
Citations 85
Authors
Affiliations
Soon will be listed here.
Abstract

Alpha-tocopheryl succinate (alpha-TOS) is a selective inducer of apoptosis in cancer cells, which involves the accumulation of reactive oxygen species (ROS). The molecular target of alpha-TOS has not been identified. Here, we show that alpha-TOS inhibits succinate dehydrogenase (SDH) activity of complex II (CII) by interacting with the proximal and distal ubiquinone (UbQ)-binding site (Q(P) and Q(D), respectively). This is based on biochemical analyses and molecular modelling, revealing similar or stronger interaction energy of alpha-TOS compared to that of UbQ for the Q(P) and Q(D) sites, respectively. CybL-mutant cells with dysfunctional CII failed to accumulate ROS and underwent apoptosis in the presence of alpha-TOS. Similar resistance was observed when CybL was knocked down with siRNA. Reconstitution of functional CII rendered CybL-mutant cells susceptible to alpha-TOS. We propose that alpha-TOS displaces UbQ in CII causing electrons generated by SDH to recombine with molecular oxygen to yield ROS. Our data highlight CII, a known tumour suppressor, as a novel target for cancer therapy.

Citing Articles

Energy metabolism in health and diseases.

Liu H, Wang S, Wang J, Guo X, Song Y, Fu K Signal Transduct Target Ther. 2025; 10(1):69.

PMID: 39966374 PMC: 11836267. DOI: 10.1038/s41392-025-02141-x.


Modification in Structures of Active Compounds in Anticancer Mitochondria-Targeted Therapy.

Pyrczak-Felczykowska A, Herman-Antosiewicz A Int J Mol Sci. 2025; 26(3).

PMID: 39941144 PMC: 11818413. DOI: 10.3390/ijms26031376.


Anticancer Potential of Tocopherols-Containing Plants and Semi-Synthetic Tocopherols.

Sianipar N, Muflikhati Z, Mangindaan D, Assidqi K Plants (Basel). 2024; 13(21).

PMID: 39519912 PMC: 11548436. DOI: 10.3390/plants13212994.


The mechanisms of action of mitochondrial targeting agents in cancer: inhibiting oxidative phosphorylation and inducing apoptosis.

Yang Y, An Y, Ren M, Wang H, Bai J, Du W Front Pharmacol. 2023; 14:1243613.

PMID: 37954849 PMC: 10635426. DOI: 10.3389/fphar.2023.1243613.


Succinate metabolism: a promising therapeutic target for inflammation, ischemia/reperfusion injury and cancer.

Zhang W, Lang R Front Cell Dev Biol. 2023; 11:1266973.

PMID: 37808079 PMC: 10556696. DOI: 10.3389/fcell.2023.1266973.


References
1.
Neuzil J, Weber T, Gellert N, Weber C . Selective cancer cell killing by alpha-tocopheryl succinate. Br J Cancer. 2001; 84(1):87-9. PMC: 2363620. DOI: 10.1054/bjoc.2000.1559. View

2.
Geschwind J, Ko Y, Torbenson M, Magee C, Pedersen P . Novel therapy for liver cancer: direct intraarterial injection of a potent inhibitor of ATP production. Cancer Res. 2002; 62(14):3909-13. View

3.
Neuzil J, Massa H . Hepatic processing determines dual activity of alpha-tocopheryl succinate: a novel paradigm for a shift in biological activity due to pro-vitamin-to-vitamin conversion. Biochem Biophys Res Commun. 2005; 327(4):1024-7. DOI: 10.1016/j.bbrc.2004.12.115. View

4.
Neuzil J, Weber T, Schroder A, Lu M, OSTERMANN G, Gellert N . Induction of cancer cell apoptosis by alpha-tocopheryl succinate: molecular pathways and structural requirements. FASEB J. 2001; 15(2):403-15. DOI: 10.1096/fj.00-0251com. View

5.
Degterev A, Lugovskoy A, Cardone M, Mulley B, Wagner G, Mitchison T . Identification of small-molecule inhibitors of interaction between the BH3 domain and Bcl-xL. Nat Cell Biol. 2001; 3(2):173-82. DOI: 10.1038/35055085. View